Mary Shoemaker
Directeur/Membre du Conseil chez TRAWS PHARMA, INC.
Fortune : 2 141 $ au 30/04/2024
Provenance du réseau au premier degré de Mary Shoemaker
| Entité | Type d'entité | Industrie | |
|---|---|---|---|
| Public Company | Biotechnology | 19 | |
| Subsidiary | Biotechnology | 4 | |
Medexus Pharma, Inc.
 Medexus Pharma, Inc. Pharmaceuticals: MajorHealth Technology Medexus Pharma, Inc. develops treatments for autoimmune diseases. It focuses on development and commercialization of treatments for autoimmune diseases as well as cancer. The company was founded in 2012 and is headquartered in Chicago, IL.
1
| Subsidiary | Pharmaceuticals: Major | 1 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Mary Shoemaker via son réseau personnel
| Société | Secteur | Personnes liées | Poste principal |
|---|---|---|---|
| AMGEN INC. | Pharmaceuticals: Major | Sales & Marketing | |
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Sales & Marketing | |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Corporate Officer/Principal | |
| ALEXION PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Sales & Marketing | |
| SPECTRUM PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Human Resources Officer | |
| ACADIA REALTY TRUST | Real Estate Investment Trusts | Director/Board Member | |
Allos Therapeutics, Inc.
 Allos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Allos Therapeutics, Inc. is a biopharmaceutical company committed to the development and commercialization of innovative anti-cancer therapeutics. It focuses on the development and commercialization FOLOTYN a pralatrexate injection. FOLOTYN is a folate analogue metabolic inhibitor designed to accumulate preferentially in cancer cells. It targets the inhibition of dihydrofolate reductase, or DHFR, an enzyme critical in the folate pathway, thereby interfering with DNA and RNA synthesis and triggering cancer cell death. Allos Therapeutics is also developing FOLOTYN in other hematologic malignancies and solid tumors. The company was founded on September 1, 1992 and is headquartered in Westminster, CO. | Pharmaceuticals: Major | Corporate Officer/Principal President | |
| SEAGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Crescendo Bioscience LLC
 Crescendo Bioscience LLC Miscellaneous Commercial ServicesCommercial Services Crescendo Bioscience, Inc. develops and commercializes quantitative blood tests for rheumatoid arthritis and other autoimmune diseases. It develops quantitative, objective, reproducible blood tests to provide rheumatologists with deeper clinical insight to help enable more effective management of patients with autoimmune and inflammatory diseases. The company was founded by Mike B. Centola and Christopher L. Sutton in July 2002 and is headquartered in South San Francisco, CA. | Miscellaneous Commercial Services | Sales & Marketing | |
| STEMLINE THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member | |
| IPI LEGACY LIQUIDATION CO | Pharmaceuticals: Major | Director/Board Member | |
| ULTRAGENYX PHARMACEUTICAL INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
SRI International
 SRI International Miscellaneous Commercial ServicesCommercial Services SRI International provides contract research and development services. It is an independent, nonprofit research institute conducting client-sponsored research and development for government agencies, commercial businesses, foundations, and other organizations. The company was founded in 1946 and is headquartered in Menlo Park, CA. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
McKinsey & Co., Inc.
 McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services McKinsey & Co., Inc. provides management consulting services. It specializes in design, marketing and sales, analytics, operations, transformation and restructuring, risk, strategy and corporate finance, and sustainability and resource productivity. The company was founded by James O. McKinsey in 1926 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| GW PHARMACEUTICALS PLC | Pharmaceuticals: Major | Corporate Officer/Principal | |
| Imperial College London | College/University | Undergraduate Degree Doctorate Degree | |
| San Diego State University | College/University | Undergraduate Degree | |
| DeSales University | College/University | Undergraduate Degree | |
| United States Naval Academy | College/University | Undergraduate Degree | |
| INSEAD | College/University | Masters Business Admin | |
| University of Connecticut | College/University | Doctorate Degree | |
| University of Calgary | College/University | Doctorate Degree Doctorate Degree | |
| INOVIO PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
Novartis Pharmaceuticals Corp.
 Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal Director/Board Member | |
| University of Bocconi | College/University | Undergraduate Degree | |
| SPEXIS AG | Pharmaceuticals: Major | Chief Executive Officer | |
| Icahn School of Medicine at Mount Sinai | College/University | Corporate Officer/Principal Corporate Officer/Principal | |
Takeda Pharmaceuticals U.S.A., Inc.
 Takeda Pharmaceuticals U.S.A., Inc. Pharmaceuticals: MajorHealth Technology Takeda Pharmaceuticals U.S.A., Inc. develops and markets pharmaceutical products. It offers metabolic and cardiovascular, respiratory and immunology, central nervous system, oncology, and general medicine products. The company was founded in 1998 and is headquartered in Deerfield, IL. | Pharmaceuticals: Major | Chief Executive Officer | |
Farmabios SpA
 Farmabios SpA Pharmaceuticals: MajorHealth Technology Farmabios SpA engages in the manufacture and marketing of active ingredients for pharmaceutical applications. It offers oral cephalosporins, steroids hormones, highly potent substances, multipurpose plant for steroids, sterile cephalosporins, sterile steroids, and antineoplastics. The company was founded in 1961 and is headquartered in Gropello Cairoli, Italy. | Pharmaceuticals: Major | Director/Board Member | |
East Bay Zoological Society
 East Bay Zoological Society Other Consumer ServicesConsumer Services East Bay Zoological Society perates as a non-profit organization that provides animal care, education center, zoo and conservation, and accommodation facilities. It also offers habitat design and the visitor experience. The company was founded by Sidney A. Snow in 1936 and is headquartered in Oakland, CA. | Other Consumer Services | Director/Board Member | |
Zambon SpA
 Zambon SpA Pharmaceuticals: MajorHealth Technology Zambon SpA is engaged in manufacturing pharmaceutical products. It offers anauran, anaurette, asacol, codex, fluimucil, and giason. The company is headquartered in Bresso, Italy. | Pharmaceuticals: Major | Director/Board Member | |
Elanco Italia SpA
 Elanco Italia SpA Pharmaceuticals: MajorHealth Technology Elanco Italia SpA operates as a global health company. It provides products, services and knowledge to prevent and treat farmed and companion animal diseases in more than 90 countries. The company is headquartered in Sesto Fiorentino, Italy. | Pharmaceuticals: Major | Chief Executive Officer | |
GeNeuro SA
 GeNeuro SA BiotechnologyHealth Technology Part of GeNeuro SA (Switzerland), the French company develops and manufactures therapeutic products. The company is based in Lyon, France. | Biotechnology | Director/Board Member | |
| Handicap International France | Director/Board Member | ||
| The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin Undergraduate Degree | |
| Bombay College of Pharmacy | College/University | Undergraduate Degree | |
Farmindustria
 Farmindustria Miscellaneous Commercial ServicesCommercial Services Farmindustria is an association of pharmaceutical companies that are based in Italy. The private company provides an interactive map that shows the location of their offices, production sites, and research centers. Farmindustria is located in Rome, Italy. The Italian company promotes the value of the pharmaceutical industry in terms of employment, investment, innovation, research and development, production, and export. The company also provides updates on COVID-19 and information on the pharmaceutical industry. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
NTC SRL
 NTC SRL Pharmaceuticals: GenericHealth Technology NTC SRL manufactures generic drugs, nutraceutical and pharmaceutical products. It develops and produces generic drugs for specialist therapies, innovative medical devices and high quality food supplements. The company was founded by Nicola Travierso in 1997 and is headquartered in Milan, Italy. | Pharmaceuticals: Generic | Director/Board Member | |
| DENALI THERAPEUTICS INC. | Biotechnology | Director/Board Member | |
| GENEURO SA | Biotechnology | Director/Board Member | |
| KUROS BIOSCIENCES AG | Biotechnology | Director/Board Member | |
| PLIANT THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
Peptomyc SL
 Peptomyc SL Pharmaceuticals: MajorHealth Technology Peptomyc SL develops cell penetrating peptides targeting the Myc oncoprotein for cancer treatment. The company was founded by Marie-Eve Beaulieu and Laura Soucek on December 16, 2014 and is headquartered in Barcelona, Spain. | Pharmaceuticals: Major | Chairman | |
Translational Development Acquisition Corp.
 Translational Development Acquisition Corp. Financial ConglomeratesFinance Translational Development Acquisition Corp. is a blank check company that was formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The company was founded on April 19, 2022 and is headquartered in New York, NY. | Financial Conglomerates | Chief Executive Officer Director/Board Member | |
| PYXIS ONCOLOGY, INC. | Pharmaceuticals: Major | Director/Board Member | |
| Pepperdine Graziadio Business School | College/University | Masters Business Admin |
Statistiques
Internationale
| Etats-Unis | 30 |
| Italie | 7 |
| France | 4 |
| Suisse | 4 |
| Royaume-Uni | 3 |
Sectorielle
| Health Technology | 29 |
| Consumer Services | 14 |
| Commercial Services | 5 |
| Finance | 3 |
Opérationnelle
| Director/Board Member | 85 |
| Corporate Officer/Principal | 55 |
| Undergraduate Degree | 21 |
| Independent Dir/Board Member | 20 |
| Chief Tech/Sci/R&D Officer | 15 |
Relations les plus connectées
| Insiders | |
|---|---|
| Michael Hoffman | 39 |
| Jack Stover | 19 |
| Viren Mehta | 17 |
| Giacomo di Nepi | 16 |
| Darren Cline | 15 |
| Abraham Noah Oler | 11 |
| Ulrich Kosciessa | 11 |
| Steven Fruchtman | 11 |
| Erik Harris | 10 |
| James Marino | 10 |
| Mark Gelder | 9 |
| Richard C. Woodman | 7 |
| Peter Atadja | 7 |
| E. Premkumar Reddy | 6 |
| Jerome Groopman | 6 |
- Bourse
- Insiders
- Mary Shoemaker
- Connexions Sociétés